Modulation of Bone and Marrow Niche by Cholesterol.
Wenzhen YinZiru LiWeizhen ZhangPublished in: Nutrients (2019)
Bone is a complex tissue composing of mineralized bone, bone cells, hematopoietic cells, marrow adipocytes, and supportive stromal cells. The homeostasis of bone and marrow niche is dynamically regulated by nutrients. The positive correlation between cardiovascular disease and osteoporosis risk suggests a close relationship between hyperlipidemia and/or hypercholesterolemia and the bone metabolism. Cholesterol and its metabolites influence the bone homeostasis through modulating the differentiation and activation of osteoblasts and osteoclasts. The effects of cholesterol on hematopoietic stem cells, including proliferation, migration, and differentiation, are also well-documented and further relate to atherosclerotic lesions. Correlation between circulating cholesterol and bone marrow adipocytes remains elusive, which seems opposite to its effects on osteoblasts. Epidemiological evidence has demonstrated that cholesterol deteriorates or benefits bone metabolism depending on the types, such as low-density lipoprotein (LDL) or high-density lipoprotein (HDL) cholesterol. In this review, we will summarize the latest progress of how cholesterol regulates bone metabolism and bone marrow microenvironment, including the hematopoiesis and marrow adiposity. Elucidation of these association and factors is of great importance in developing therapeutic options for bone related diseases under hypercholesterolemic conditions.
Keyphrases
- low density lipoprotein
- bone mineral density
- bone marrow
- stem cells
- bone loss
- bone regeneration
- soft tissue
- cardiovascular disease
- postmenopausal women
- adipose tissue
- induced apoptosis
- mesenchymal stem cells
- high density
- insulin resistance
- risk assessment
- body mass index
- type diabetes
- coronary artery disease
- physical activity
- cell therapy
- cell cycle arrest
- weight gain